ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo aims to halt prostate cancer in its tracks
Disease control Not yet recruitingThis study tests whether a vaccine (TriAdeno) plus a drug (N-803) can stop early-stage prostate cancer from getting worse. About 52 men with low- or medium-risk prostate cancer who are currently under active surveillance will receive four cycles of injections. The goal is to see …
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New hope for stomach cancer: targeted drug combo enters final trial phase
Disease control Not yet recruitingThis study tests a new two-drug combination (tecotabart vedotin plus tislelizumab) against the standard treatment (tislelizumab plus chemotherapy) for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if the new …
Matched conditions: ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC